From tissue-specific to tissue-agnostic: HER2 overexpression and the rise of antibody-drug conjugates by Heidi C. Ko, Kyle C. Strickland, Kyle C. Strickland, Dana Jaggessarsingh, Alicia Dillard, Michelle Green, Erin Newburn, Tiffany Sellaro, Jonathan L. Klein, Brian Caveney, Marcia Eisenberg, Eric A. Severson, Shakti Ramkissoon, Shakti Ramkissoon, Rebecca A. Previs, Rebecca A. Previs, Anis Toumeh

Get full text

A pilot study investigating the effect of pembrolizumab on the tumoral immunoprofile of newly diagnosed mullerian cancers by Stéphanie L. Gaillard, Gloria Broadwater, Andrew Berchuck, William S. Andrews, Laura J. Havrilesky, Brittany A. Davidson, Rebecca A. Previs, Mark D. Starr, John S. Yi, Andrew B. Nixon, Jadee L. Neff, Jose Ramon Conejo-Garcia, Angeles Alvarez Secord

Get full text

RB1 expression and HR proficiency define a poor prognosis subtype of high grade serous ovarian cancer by Kyle C. Strickland, Zachary D. Wallen, Heidi C. Ko, Michelle F. Green, Alicia Dillard, Sarabjot Pabla, Stephanie Hastings, Alison Roos, Taylor J. Jensen, Marcia Eisenberg, Brian J. Caveney, Shakti Ramkissoon, Eric A. Severson, Rebecca A. Previs

Get full text

RNA hybrid-capture next-generation sequencing has high sensitivity in identifying known and less characterized oncogenic and likely oncogenic NTRK fusions in a real-world standard-... by Zachary D. Wallen, Marni Tierno, Erica Schnettler, Alison Roos, Michelle Green, Kobina Amoah, Rebecca A. Previs, Stephanie Hastings, Sarabjot Pabla, Taylor J. Jensen, Brian Caveney, Marcia Eisenberg, Pratheesh Sathyan, Shakti H. Ramkissoon, Shakti H. Ramkissoon, Eric A. Severson

Get full text